BackAquestive Therapeutics Overview

Aquestive Therapeutics Total Revenue

Revenue analysis for AQST.

Quarterly Revenue

$14.45M
65.67% YoY

As of Mar 2026

Annual Revenue (TTM)

$50.27M
7.3% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading